Delcath Systems Appoints Vojislav Vukovic As Chief Medical Officer
06/20/23, 12:30 PM
Location
new yorkIndustry
biotechnology
Position
chief medical officer
Delcath Systems, Inc. , an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, is pleased to announce the appointment of Dr. Vojislav \"Vojo\" Vukovic as its new Chief Medical Officer .
Company Info
Location
1633 broadway
new york, new york, united states
Additional Info
Delcath Systems, Inc. (NASDAQ- DCTH) is a specialty pharmaceutical and medical device company focused on the treatment of primary and metastatic liver cancers. Our proprietary product---Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS)---is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure.